Patient was prescribed a 5-fluorouracil home infusion to be administered via an elastomeric pump over 46 hours.Administration began on wednesday (b)(6) 2020.When the patient returned to have the infusion unhooked on friday (b)(6) 2020, the nurse noticed the infuser pump was completely full and very little, if any, medication had been delivered to the patient.After investigation of the process, it was noted that the pump was filled and hooked up to the patient appropriately.The pump tubing had been primed with 0.9% sodium chloride and fluid had made it completely through the tubing down to the patient end.The patient's port flushed appropriately.When the pump was tested after removal from the patient, the fluid did not flow as it should, indicating a defect in the pump.The manufacturer was notified of the issue.Fda safety report id# (b)(4).
|